Mahin Ghavami
Mashhad university of medical science
About the Genetic Disease Session
An illness characterised by one or more anomalies in the genome is referred to as a genetic condition. It can be brought on by a chromosomal aberration, a mutation in a single gene (monogenic), a number of genes (polygenic), or both. The phrase is typically used when addressing illnesses having a single genetic origin, either in a gene or chromosome, even though polygenic disorders are the most prevalent. De novo mutations occur spontaneously before embryonic development. Autosomal recessive inheritance occurs when two parents carry the same defective gene, or when a parent already has the condition (autosomal dominant inheritance). A genetic ailment is also categorised as a hereditary disease if it is inherited from either one or both parents.
Topics Covered in Genetic Disease
Topic 01
Monogenic and chromosomal disorders
Topic 02
Inheritance patterns and family risk
Topic 03
De novo mutations and congenital anomalies
Topic 04
Genetic counselling and carrier screening
Topic 05
Rare disease diagnosis and management
Topic 06
Gene therapy and emerging treatments
Featured Speakers — Genetic Disease 2027
Recent Research Presented at Genetic Disease Sessions
National mortality and years of potential life lost due to hemophilia in Iran, 2014–2025: A registry-based study
Introduction: Hemophilia is a rare inherited bleeding disorder associated with premature mortality, particularly where access to comprehensive care is limited. Nationwide evidence on mortality and…
Health related quality of life of under five children with down syndrome and sociodemographic correlates
Background: Many researchers have revealed that Health Related Quality of Life (HRQOL) is significantly related to multiple socio-demographic factors in the general population. Only one previous…
Related Scientific Sessions at IPHC 2027
Why Attend the Genetic Disease Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Genetic Disease work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Genetic Disease research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Genetic Disease track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Genetic Disease Conference 2027 — FAQs
What is the Genetic Disease track at IPHC 2027?
The Genetic Disease track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Genetic Disease. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Genetic Disease sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Genetic Disease are all welcome — whether presenting or attending.
Can I present my research in the Genetic Disease track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Genetic Disease sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Genetic Disease track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.